OptiBiotix Health plc (LON:OPTI) has appointed a director of business development with a strong scientific background.
The company, which is focused on altering the function of the human biome to tackle obesity, cholesterol, diabetes and skin conditions, said Luis Gosalbez will join the senior management team.
Gosalbez brings a strong scientific background, an understanding of the microbiome and expertise in consumer healthcare, probiotics and the development of novel live biotherapeutic products, the company said.
The multi-lingual Gosalbez has at various times worked in Germany, Spain and South Korea as a researcher, analyst, and as a director of strategic products exploring opportunities in consumer healthcare the microbiome and biotherapeutics.
“Luis’s scientific and commercial experience in the microbiome space across food, biotech, and pharma provides additional breadth and capability to help capitalise on the growing number of microbiome opportunities,” said Stephen O’Hara, chief executive of OptiBiotix.
“His multilingual skills and experience in working in overseas markets, particularly Asia, will help enhance our access to these markets and support commercialisation of our pipeline of opportunities. Luis's skills in managing multiple projects brings additional capacity to manage the increasing number of product development agreements currently in place with international partners, in addition to those anticipated in the future," O’Hara added.